Monthly Update: Anti-infectives: VAQTA: Merck's hepatitis A vaccine, purified, inactivated

References

• PROVOST PJ, HITIFMAN MR: An inactivated hepatitis Avirus vaccine prepared from infected Marmoset liver. Proceedings of the Society for Experimental Biology and Medicine (1987) 159:201–203.
   Google Scholar
• PROVOST PJ, GLESA PA, MCALEER WJ, HILLEMAN MR:Isolation of hepatitis A virus in vitro in cell culture directly from human specimens. Proceedings of the Soci-ety for Experimental Biology and Medicine (1981) 167:201–206.
   PubMed Web of Science ®Google Scholar
• PROVOST PJ, HILLEMAN MR: Propagation of humanhepatitis A virus in cell culture in vitro. Proceedings of the Society for Experimental Biology and Medicine (1979) 160:213–221.
   PubMed Web of Science ®Google Scholar
• PROVOST PJ, HUGHES JV, MILLER WJ, GIESA PA, BANKERFS, EMINI EA: An inactivated hepatitis A virus vaccine of cell culture origin. J. Med. Virology (1986) 19:23–31.
   PubMed Web of Science ®Google Scholar
• MIDTHUN K, EII.FRBECK E, GERSHMAN K, CALANDRA G,KRAH D, MCCAUGHTRY M, NALIN D, PROVOST P: Safety and inununogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers J. Infect. Dis. (1991) 163:735–739.
   Google Scholar
• PROVOST PJ, BISHOP RP, GERETY RJ, HILLEMAN MR,MCALEER WJ, SCOLNICK EM, STEVENS CE: New findings In live, attenuated hepatitis A vaccine development J. Med. Virology (1986) 20:165–175.
   PubMed Web of Science ®Google Scholar
• ELLERBECK E, LEWIS J, MIDTHUN K, GERSHMAN K, NALIND, MCCAUGHTRY M, PROVOST P, CALANDRA G: Safety and hrununogenicity of an inactivated hepatitis A virus vaccine. In: Viral Hepatitis and Liver Disease: Proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease: Contemporary Issues and Future Prospects. Hollinger FB, Lemon SM, Margolis H (Eds.). Williams & Wilkins, Baltimore (1991):91–93.
   Google Scholar
• LEWIS JA, ARMSTRONG ME, LARSON VM, EMINI EA,MIDTHUN K, ELLERBECK E, NALIN D, PROVOST PJ, CA-LANDRA GB: Use of a live, attenuated hepatitis A vaccine to prepare a highly purified, formalin-inactivated hepa-titis A vaccine. In: Viral Hepatitis and Liver Disease: Pro-ceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease: Contemporary Issues and Future Prospects. Hollinger FB, Lemon SM, Margolis H (Eds.). Wil-liams & Wilkins, Baltimore (1991):94–97.
   Google Scholar
• WERZBERGER A, MENSCH B, KUTER B, ETAL.: A control-led trial of a formalin-inactivated hepatitis A vaccine in healthy children. New Engl. J. Med. (1992) 327(7):453–457.
   Google Scholar
• STAPLETON JT, JANSEN R, LEMON SM: Neutralizing anti-body to hepatitis A virus in immune serum globulin and In the sera of human recipients of immune serum globulin. Gastroenterology (1985) 89:637–642.
   PubMed Web of Science ®Google Scholar
• WINOKUR PL, STAPLETON JT: Immunoglobulin prophy-laxis for hepatitis A. ain. Infect. Dis. (1992) 14:580–586.
   Web of Science ®Google Scholar
• CONRAD ME, LEMON SM: Prevention of endemic kterk viral hepatitis by administration of immune serum gamma globulin. J. Infect. Dis. (1987) 156(1)56–63.
   Google Scholar
• STOKES J, Jr., NEEFE JR: The prevention and attenuation of infectious hepatitis by gamma globulin. JAMA (1945) 127:144–145.
   Web of Science ®Google Scholar
• STOKES J, Jr., FARQUHAR JA, DRAKE ME, CAPPS RB, WARDCS, Jr.: Infectious hepatitis - Length of protection by Immune serum globulin (gamma globulin) during epi-demics. JAMA (1951) 147:714–719.
   Google Scholar
• WOODSON RD, CLINTON JJ: Hepatitis A prophylaxisabroad. Effectiveness of immune serum globulin pro-tecting Peace Corps volunteers. JAMA (1969) 209(7):1053–1058.
   Google Scholar
• CONRAD ME: Prophylactic gamma globulin for preven-tion of endemic hepatitis. Effects of U.S. gamma globu-lin upon the inddence of viral hepatitis and other Infectious diseases in U.S. soldiers abroad. Arch. Int . Med. (1971) 128(5):723–728.
   Google Scholar
• KRUGMAN S: Effect of human immune serum globulinon infectivity of hepatitis A virus. J. Infect. Dis. (1976) 134(1):70–74.
   PubMed Web of Science ®Google Scholar
• KARK JD: Pre-exposure prophylaxis with immune se-rum globulin for prevention of viral hepatitis in Army recruits. J. Epidemiol. Commun. Health (1982) 36(3):176–182.
   PubMed Web of Science ®Google Scholar
• KARK JD: Pre-exposure prophylaxis of viral hepatitiswith immune serum globulin man endemic area. A trial in field units of the Israel Defense Forces. Scand.J. Infect. Dis. (1983) 15:3–6.
   PubMed Web of Science ®Google Scholar
• GREEN MS, DOTAN K: Efficacy of immune serum globu-lin in an outbreak of hepatitis A virus infection in adults. J. Infect. (1988) 17:265–270.
   PubMed Web of Science ®Google Scholar
• PAVIA AT, NIELSEN L, ARMINGTON L, THURMAN DJ, TIERNEY E, NICHOLS CR: A community-wide outbreak of hepatitis A in a religious community: Impact of mass administration of immune globulin. Am. J. Epidemiol. (1990) 131(6):1085–1093.
   PubMed Web of Science ®Google Scholar
• LERMAN Y, SHOHAT T, ASHKENAZI S, ALMOG R, HEERINGSL, SHEMER J: Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: A three-year prospective study. Clin. Infect. Dis. (1993) 17:411–414.
   PubMed Web of Science ®Google Scholar
• SHOUVAL D, ASHUR Y, ADLER R, ET AL.: Single and booster dose responses to an inactivated hepatitis A virus vaccine: Comparison with immune serum globu-lin prophylaxis. Vaccine (1993) 11\(Suppl. 1):S9–14.
   Google Scholar
• MILLER WJ, CLARK W, HURNI W, KUTER B, SCHOFIELD T,NALIN D: Sensitive assays for hepatitis A antibodies. J. Med. Virology (1993) 41:201–204.
   PubMed Web of Science ®Google Scholar
• VILLAREJOS VM, JAIME SERRA C, ANDERSON-VISONA K, MOSLEY JW: Hepatitis A virus infection in households. Am. J. Epidemiol. (1982) 115(4):577–586.
   PubMed Web of Science ®Google Scholar
• NALIN DR: VAQTA® hepatitis A vaccine, purified, inacti-vated. Drugs of the Future (1995) 20(1):24–29.
   Google Scholar
• HADLER SC: Global impact of hepatitis A virus infection changing patterns. In: Viral Hepatitis and Liver Disease: Proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease: Contemporary Issues and Future Prospects. Hollinger FB, Lemon SM, Margolis H (Eds.). Wil-liams & Wilkins, Baltimore (1991):14–20.
   Google Scholar